Registry of Valvular Heart Disease in Hospitalized Adults in China
Official title: A Prospective, Single-center,Registry Study of Chinese Hospitalized Adult Patients With Valvular Heart Disease
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT03011697 · Data updated 2026-11-12
This study is trying to gather information about adults in China who are hospitalized with valvular heart disease to better understand how common it is, how it's treated, and what the outcomes are.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | February 1, 2017 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | July 15, 2021 |
| Trial ID | NCT03011697 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are hospitalized adults over 18 years old with moderate or severe valvular heart disease as defined by echocardiographic criteria.
✕Probably not a fit
Patients with mild valvular heart disease or those not hospitalized may not receive benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to gather contemporary data on the prevalence, characteristics, risk stratification, cost-effectiveness, treatments, and prognosis of hospitalized adult patients with valvular heart disease in China. Given the increasing frequency of valvular heart disease, particularly among the aging population, this study seeks to address the gaps in understanding its impact in developing countries. By focusing on hospitalized patients over 18 years old with moderate or severe valvular conditions, the study will provide valuable insights into the management and outcomes of this patient population.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and treatment of valvular heart disease in Chinese patients, leading to improved patient outcomes.
How similar studies have gone: While similar studies have been conducted, this specific observational cohort approach focusing on the Chinese population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Hospitalized patients over 18 years old meet one of the following conditions. 1. moderate or above valvular heart disease as defined by echocardiography: 1.1 Aortic stenosis, moderate or above, or valve area ≤1.5cm2, or maximal jet velocity ≥3.0m/sec, or mean pressure gradient ≥20mmHg, 1.2 Aortic regurgitation, moderate or above, or jet width ≥25% of left ventricular outflow tract, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, 1.3 Mitral stenosis, moderate or above, or valve area ≤2.0cm2, 1.4 Mitral regurgitation, moderate or above, or effective regurgitant orifice ≥0.2cm2, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, 1.5 Tricuspid stenosis, moderate or above, or valve area ≤1.0cm2, 1.6 Tricuspid regurgitation, moderate or above, or central jet area ≥5.0cm2, 1.7 Pulmonic stenosis, moderate or above, or maximal jet velocity \>4m/sec, 1.8 Pulmonic regurgitation, moderate or above, 2. Patients who had undergone any operation on a cardiac valve (percutaneous balloon commissurotomy, valve repair, valve replacement, transcatheter aortic valve implantation), 3. Diagnosis of endocarditis as assessed by Duke criteria. Exclusion Criteria: 1. Patients cannot be followed up for any reasons. 2. Patients in critical condition may be die in one year. 3. Patients have been enrolled in this study.
Where it's running
-
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Wang Jian-an, MD,PhD — Second Affiliated Hospital, Zhejiang University, School of Medicine
- Study coordinator: Liu Xianbao, MD
- Email: liuxb2009@hotmail.com
- Phone: +86-13857173887
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Heart sound signals to detect valve and artery disease early
This observational study tests whether a new digital stethoscope-like device can pick up heart sound patterns to detect valvular or coronary artery disease earlier in people who are already getting heart imaging.
-
Pulmonary Vascular Disease in Valvular Heart Disease: How Valve Procedures Affect Blood Flow
This study tests how blood flow in the lungs changes in adults with left-sided valve disease who are having valve surgery and looks to see if patterns can predict reversibility of tricuspid regurgitation and right heart dysfunction.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
MMVD: A Multicenter Registry to Understand Multiple and Mixed Valvular Heart Disease
This study tests how common MMVD is, what imaging and management practices are used, and what factors influence outcomes in adults with two or more valve issues.
-
Aortic valve sizing: comparing CT scan measurements with measurements taken during surgery for people having surgical aortic valve replacement
This will see if CT scan measurements match the aortic valve sizes surgeons measure during surgical aortic valve replacement in adults with severe aortic stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.